Angry Gut: Irritable Bowel Syndrome

Abstract

Irritable bowel syndrome (IBS) is a functional disorder of the intestine characterized by abdominal pain and altered bowel habits. At present, no biological marker has been identified. Hence, the disease is clinically assessed on the basis of the symptoms according to ROME IV criteria. Epidemiological data revealed that the prevalence of IBS varies widely around the world, and more thorough research is needed to pinpoint any discrepancies that may exist between countries, as well as possible reasons. Both pharmacological and non-pharmacological therapy is being used in order to treat IBS. There is no specific treatment for irritable bowel disease that has come across the patients and only possible measures have been taken to treat the severity of symptoms. Symptomatic treatment with spasmolytic agent like mebeverine has been considered a standard therapy to relieve pain but to deal with constipation and diarrhea different treatment modalities have been adopted by the physician